CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for CRISPR Therapeutics AG stock ranges from a low of $32 to a high of $120. The average analyst price target of $72.27 forecasts a 26.06% increase in the stock price over the next year.

Price Target: $72.27 (+26.06%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$32	$72.27	$80	$120
Change	-44.18%	+26.06%	+39.54%	+109.31%

Analyst Ratings

The average analyst rating for CRISPR Therapeutics AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	7	6	6	6	6	6
Buy	4	4	3	3	3	3
Hold	9	8	6	7	6	6
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	21	19	16	17	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $65 → $80	Strong Buy	Maintains	$65 → $80	+39.54%	Aug 7, 2025
Gena Wang Barclays	Barclays	Hold Maintains $42 → $56	Hold	Maintains	$42 → $56	-2.32%	Aug 6, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $82	Strong Buy	Maintains	$82	+43.03%	Aug 5, 2025
Luca Issi RBC Capital	RBC Capital	Hold Maintains $38 → $42	Hold	Maintains	$38 → $42	-26.74%	Aug 5, 2025
Geoff Meacham B of A Securities	B of A Securities	Strong Buy Maintains $79 → $78	Strong Buy	Maintains	$79 → $78	+36.05%	Jul 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

47.88M

Increased by 28.31%

from 37.31M

Revenue Next Year

176.21M

Increased by 268.05%

from 47.88M

EPS This Year

-5.53

from -4.34

EPS Next Year

-4.56

from -5.53

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	719.00K	914.96M	1.20M	371.21M	37.31M	47.88M	176.21M	410.76M
Revenue Growth	-99.75%	127,154.94%	-99.87%	30,885.48%	-89.95%	28.31%	268.05%	133.11%
EPS	-5.29	4.70	-8.36	-1.94	-4.34	-5.53	-4.56	-3.55
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	31	30	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	150.2M	1.6B	2.4B
Avg	47.9M	176.2M	410.8M
Low	n/a	n/a	37.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	302.4%	3,145.8%	1,250.7%
Avg	28.3%	268.0%	133.1%
Low	-	-	-78.9%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-4.00	2.68	4.94
Avg	-5.53	-4.56	-3.55
Low	-6.58	-6.68	-7.60

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.